Beraud Jill — SEC Form 4 filings
SEC reporting owner CIK 1520061. 16 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-27 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LEVI STRAUSS & CO (LEVI) | Director | 14 | — | — | 27 |
| Revance Therapeutics, Inc. (RVNC) | Director | 2 | — | — | 4 |
Form 4 filings — Beraud Jill
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 54 @ $0 · Grant/award (A): 92 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 50 @ $0 · Grant/award (A): 86 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 8,381 @ $0 | EDGAR |
| 2026-02-27 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 75 @ $0 · Grant/award (A): 89 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 85 @ $0 · Grant/award (A): 101 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 82 @ $0 · Grant/award (A): 97 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 88 @ $0 · Grant/award (A): 104 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | LEVI STRAUSS & CO (LEVI) | Conversion (C): 108,679 @ $0 · Grant/award (A): 11,690 @ $0 · Conversion (C): 108,679 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 56 @ $0 · Grant/award (A): 99 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Revance Therapeutics, Inc. (RVNC) | Code (U): 28,606 @ $3.65 · Disposition to issuer (D): 15,000 | EDGAR |
| 2024-11-18 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 60 @ $0 · Grant/award (A): 106 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 52 @ $0 · Grant/award (A): 93 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 42 @ $0 · Grant/award (A): 74 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Revance Therapeutics, Inc. (RVNC) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 23,458 (derivative) @ $0 | EDGAR |
| 2024-04-26 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 7,642 @ $0 | EDGAR |
| 2024-02-27 | 4 | LEVI STRAUSS & CO (LEVI) | Grant/award (A): 69 @ $0 · Grant/award (A): 88 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1520061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →